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 4 
 Haemophilus parasuis is the causative agent of a disease, Glässer’s disease, that was 5 
once regarded as a sporadic disease of young stressed pigs (Rapp-Gabrielson et al., 2006). 6 
However, there is no doubt that modern pig production systems have resulted in the 7 
emergence of this agent as a major cause of economic loss to pig industries around the world 8 
(Aragon et al., 2012). This emergence of a once sporadic disease has highlighted the need to 9 
understand the virulence mechanisms of this pathogen. A timely review by Drs Mar Costa-10 
Hurtado and Virginia Aragon of the Universitat Autònoma de Barcelona, published in this 11 
issue of The Veterinary Journal, provides a comprehensive overview of our current 12 
knowledge of the virulence factors of H. parasuis (Costa-Hurtado and Aragon, 2013). 13 
 14 
 While the review makes clear that there has been considerable research in the area, it 15 
is clear that progress towards a more complete understanding of the virulence mechanisms of 16 
this key pathogen has been limited by a number of issues: 1) a very difficult challenge model; 17 
2) the diversity of isolates present as both colonisers of the upper respiratory tract and in 18 
disease outbreaks; and 3) the range in virulence seen in ‘virulent’ H. parasuis isolates. The 19 
result of these limitations, as is clearly shown in the review by Costa-Hurtado and Aragon 20 
(2013), is that there are few factors that are clearly and definitely associated with virulence. 21 
 22 
 The ability to perform challenge trials in a realistic and practical setting is a key 23 
capacity. It is interesting to note that close relatives of H. parasuis, such as Avibacterium 24 
paragallinarum and Actinobacillus pleuropneumoniae, are organisms in which challenge 25 
models are easy to perform, use an upper respiratory tract challenge and involve conventional 26 
naïve animals, as shown in studies from our group (Tumamao et al., 2004; Gong et al., 2013). 27 
In contrast, the models used to reproduce Glässer’s disease are difficult to use, involve 28 
unrealistic challenge methods that by-pass typical upper respiratory tract defences or use 29 
animals lacking a normal immune capacity. The models have included intra-peritoneal 30 
injection of specific-pathogen-free pigs (Kielstein and Rapp-Gabrielson, 1992), intranasal 31 
challenge of snatch farrowed colostrum deprived piglets (Aragon et al., 2010) or intra-tracheal 32 
challenge of snatch farrowed colostrum deprived piglets (Turni and Blackall, 2007). 33 
 34 
Falkow (1988) introduced the concept of ‘molecular Koch’s postulates’ (identifying a 35 
potential virulence-linked gene, knocking out that gene and then showing that the mutant has 36 
no or reduced virulence, while the restored mutant returns to full virulence), the application of 37 
which has provided significant insight into many pathogens (Falkow, 2004). With H. 38 
parasuis, studies seeking to utilise an approach such as the molecular Koch’s postulates to 39 
confirm the role of a virulence factor have a major problem: the difficulty performing 40 
pathogenicity trials. There is no doubt that this challenge is major reason why we have so 41 
little definitive knowledge on the virulence factors of H. parasuis. While some studies have 42 
elected to use a mouse model (presumably to overcome the difficulty and expense of the 43 
available pig models), this model is not particularly relevant. Morozumi et al. (1982) showed 44 
that H. parasuis can cause death but with few, if any, lesions in a mouse model. 45 
 46 
As noted in the review by Costa-Hurtado and Aragon (2013), the literature contains 47 
many studies comparing and contrasting ‘virulent’ and ‘non-virulent’ strains and isolates. 48 
Since pathogenicity screening is so difficult, these studies on potential virulence mechanisms 49 
often have to compare and contrast nasal isolates from herds/animals with no history of 50 
clinical Glässer’s disease (assumed to be non-virulent) and isolates obtained from normally 51 
sterile sites in disease pigs (assumed to be virulent); for example, the study on serum 52 
resistance by Cerdà-Cuéllar and Aragon (2008). While such comparative studies have 53 
advanced our understanding, there are clear limitations to such studies. Multiple 54 
genotypes/serovars of H. parasuis can be present in the upper respiratory tract of a pig (Turni 55 
and Blackall, 2010). In addition, multiple genotypes/serovars can be present in isolates 56 
obtained from diseased pigs within a farm (Oliveira et al., 2003). Clearly, under these 57 
circumstances, assigning isolates to ‘virulent’ and ‘non-virulent’ categories by site source and 58 
herd clinical history will result in misclassification of some isolates (in both categories). As 59 
an additional issue, the diverse genetic backgrounds of such collections of isolates means that 60 
the clear elegance possible in the classic molecular Koch’s postulates is missing in such group 61 
comparisons. 62 
 63 
A final issue that has made work on the virulence mechanisms of H. parasuis so 64 
challenging is the variation in virulence across ‘virulent’ isolates. A simple dichotomy, 65 
‘virulent’ and ‘non-virulent’ does not reflect the complexity of the situation seen in the field 66 
and in experimental infections. From the work of Kielstein and Rapp-Gabrielson (1992) 67 
onwards, it has been clear that there are degrees of virulence in ‘virulent’ H. parasuis. As an 68 
example, we examined two H. parasuis strains (H425 and HS1387) in a catch-farrow, 69 
colostrum deprived pig model (Turni and Blackall, 2007). While both strains were virulent, 70 
there were major differences in the outcomes; the H425 strain caused a disease that 71 
progressed so rapidly that all seven pigs had to be euthanased within 4 days. In contrast, 7/9 72 
pigs given HS1387 survived the experiment. While all seven pigs given strain H425 yielded 73 
H. parasuis from the brain, only 1/9 HS1387 infected pigs yielded H. parasuis from the brain. 74 
In contrast, the level of peritonitis in the HS1387 infected pigs was markedly more severe 75 
than that seen in the H425 infected pigs (Turni and Blackall, 2007). While there is no doubt 76 
that both strains examined in our study were ‘virulent’, the different disease expressions 77 
(essentially acute septicaemia as compared with severe peritonitis within a single pig 78 
population) clearly flag that there are major differences in the virulence mechanisms within 79 
‘virulent’ strains, as well as between ‘virulent’ and ‘non-virulent’ strains. 80 
 81 
Such variation in disease expression is also seen in field outbreaks. While the majority 82 
of outbreaks of Glässer’s disease involve polyserositis (Rapp-Gabrielson et al., 2006), there 83 
are field reports, such as that of Peet et al. (1983), of an acute septicaemic disease with 84 
minimal serosal inflammation. Clearly, the interpretation of differing disease expression seen 85 
in different field outbreaks involves the complicating, additional factors of host variation and 86 
farm management. However, the results of the experimental infections in studies such as that 87 
of Kielstein and Rapp-Gabrielson (1992) and our own work (Turni and Blackall, 2007) is 88 
quite clear: considerable diversity exists within the concept of ‘virulence’ as applied to H. 89 
parasuis. 90 
 91 
Given the above challenges, it is not at all surprising that, as noted by Costa-Hurtado 92 
and Aragon (2013), so little definitive knowledge exists on the virulence mechanisms of H. 93 
parasuis. An ability to reproduce the disease, with the use of colostrum-deprived piglets that 94 
have been either catch or snatch farrowed appearing to be the best current option, and an 95 
appreciation of the range in virulence within ‘virulent’ H. parasuis, will underpin further 96 
progress in this area. 97 
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